Sintx Technologies Files Proxy Materials

TL;DR

SINTX filed proxy docs, no fee. Governance in motion.

AI Summary

Sintx Technologies, Inc. filed a Definitive Additional Materials proxy statement on November 26, 2024. This filing is related to the company's proxy materials and does not involve a fee. Sintx Technologies, formerly Amedica Corp, is incorporated in Delaware and operates in the surgical and medical instruments sector.

Why It Matters

This filing indicates that Sintx Technologies is proceeding with corporate governance matters, which are essential for shareholder communication and decision-making processes.

Risk Assessment

Risk Level: low — This is a routine administrative filing related to proxy statements and does not contain new financial information or strategic changes that would inherently increase risk.

Key Players & Entities

• Sintx Technologies, Inc. (company) — Registrant
• AMEDICA Corp (company) — Former company name
• 20241126 (date) — Filing date

FAQ

Key Financial Figures

• $100 million — ord of success, including securing over $100 million in funding for SINTX and its predecesso
• $5 million — filing, the company holds approximately $5 million in cash and cash equivalents. While rev
• $500,000 — ock buyback program to repurchase up to $500,000 dollars (20% of outstanding common shar

Filing Documents

• formdefa14a.htm (DEFA14A) — 38KB
• formdefa14a_001.jpg (GRAPHIC) — 8KB
• 0001493152-24-047718.txt ( ) — 50KB

From the Filing

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Securities Exchange Act of 1934 Filed by the Registrant Filed by a Party other than the Registrant Check the appropriate box: Preliminary Proxy Statement Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) Definitive Proxy Statement Definitive Additional Materials Soliciting Material Pursuant to Section 240.14a-12 SINTX TECHNOLOGIES, INC. (Name of Registrant as Specified in Its Charter) (Name of Persons Filing Proxy Statement If Other Than the Registrant) Payment of Filing Fee (Check the appropriate box): No fee required. Fee paid previously with preliminary materials. Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11. IMPORTANT NOTICE Please exercise your right to vote as soon as possible! Dear Shareholders, We recently sent you a Proxy Statement concerning important proposals affecting your investment in SINTX Technologies, Inc. which will be considered at the Annual Meeting of Shareholders on December 19, 2024 at 10:00 a.m. Mountain Time. This letter was sent to you because you held shares in SINTX Technologies on the record date and we have not received your vote. THE SINTX BOARD RECOMMENDS THAT YOU VOTE “FOR” THE PROPOSALS YOUR VOTE IS VERY IMPORTANT VOTING NOW HELPS MINIMIZE PROXY COSTS, AVOIDS UNNECESSARY COMMUNICATIONS AND ELIMINATES PHONE CALLS TO SHAREHOLDERS Please vote using one of the following options: 1. VOTE ONLINE Log on to the website AT www.proxyvote.com . Please Have your proxy card in hand when you access the web site and follow the instructions to obtain your records and to create an electronic voting instruction form. 2. VOTE BY TOUCH-TONE TELEPHONE 1-800-690-6903 Use any touch-tone telephone to transmit your voting instructions up until 11:59 p.m. Eastern Time the day before the cut-off date or meeting date. Have your proxy card in hand when you call and then follow the instructions. 3. VOTE BY MAIL Mark, sign and date your proxy card and return it in the postage-paid envelope we have provided or return it to Vote Processing, c/o Broadridge, 51 Mercedes Way, Edgewood, NY 11717. The Proxy Statement sent previously contains important information regarding the proposals that you and other shareholders are being asked to consider. A copy of the Proxy Statement may be viewed or downloaded at the website listed on your enclosed proxy card. Please read the materials carefully Thank you for your prompt attention to this matter. If you have already voted, we appreciate your participation. Corporate Update: Progress and Strategic Vision I am pleased to provide you with a year-end update on the current state of SINTX Technologies, Inc., our progress over the past months, and the strategic steps we are taking to position the company for growth and long-term value creation. Transparency and open communication remain a cornerstone of our relationship with shareholders, and I hope this detailed update reflects our commitment to keeping you informed. Refocusing on Medical Device Innovation As detailed in our recent filings, SINTX Technologies is undergoing a strategic transformation to refocus on the medical device sector, building on our legacy of innovation in silicon nitride technology. We believe this refined direction best aligns with the company’s strengths and the significant market opportunities in healthcare. Our aim is to provide advanced solutions in orthopedics, spinal fusion, and infection control, leveraging our proprietary materials to address pressing needs in patient care. Leadership Changes to Strengthen Strategic Execution In alignment with this refocus, we are excited to announce that Gregg R. Honigblum has been appointed as our Chief Strategy Officer. Gregg brings an extensive track record of success, including securing over $100 million in funding for SINTX and its predecessor company, Amedica. His role will encompass fund raising initiatives, investor relations, and refining our corporate strategy. With Gregg’s leadership, we are confident in our ability to strengthen SINTX’s financial health and operational focus. Financial Position and Operational Efficiency SINTX’s latest financial disclosures contained in the Quarterly Report (10-Q) ended September 2024, highlight our ongoing efforts to reduce costs and streamline operations. As of our most recent filing, the company holds approximately $5 million in cash and cash equivalents. While revenue generation remains a challenge, we have successfully identified opportunities to reduce our lease liabilities and optimize our operational footprint, including active negotiations to reduce our lease liability. In addition, we have initiated a stock buyback program to repurchase up to $500,000 dollars (20% of outstanding common shares), reflecting our c

View Full Filing

View this DEFA14A filing on SEC EDGAR